AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1114.905.1 (+0.46 %)
PREV CLOSE ( ) 1109.80
OPEN PRICE ( ) 1111.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 70914
TODAY'S LOW / HIGH ( )1095.70 1128.40
52 WK LOW / HIGH ( )556.2 1177
NSE1114.503.4 (+0.31 %)
PREV CLOSE( ) 1111.10
OPEN PRICE ( ) 1113.85
BID PRICE (QTY) 1114.50 (6)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2027734
TODAY'S LOW / HIGH( ) 1095.80 1129.00
52 WK LOW / HIGH ( )556.1 1177.1
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax26125.0033727.4073435.9037430.4030913.50
Adjustment15864.7013441.30-16626.4010911.708139.50
Changes In working Capital-10949.8015578.00-10666.503079.10-14845.00
Cash Flow after changes in Working Capital31039.9062746.7046143.0051421.2024208.00
Cash Flow from Operating Activities23867.5050164.8033290.5043812.8016509.70
Cash Flow from Investing Activities-39777.50-32115.605986.90-15676.40-29025.90
Cash Flow from Financing Activities18144.10-29692.70-13649.40-19471.8019190.60
Net Cash Inflow / Outflow2234.10-11643.5025628.008664.606674.40
Opening Cash & Cash Equivalents41625.1053299.1027468.2018755.8012099.40
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidations64.10-32.50224.10NANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations-0.602.00-21.2047.80-18.00
Closing Cash & Cash Equivalent43922.7041625.1053299.1027468.2018755.80

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.